About Matt Rightmire

This author has not yet filled in any details.
So far Matt Rightmire has created 71 blog entries.

Covetrus Celebrates Launch as Newly Formed Public Company

Covetrus (NASDAQ:CVET) celebrates the combination of two unique and complementary businesses – Henry Schein Animal Health and Vets First Choice – as a newly formed company. Covetrus will leverage decades-long experience, insights, technology and global scale to empower veterinarians to enhance clinical and practice health. Read More

By | February 14th, 2019|News|

Teckro raises $25 million Series C financing

Teckro has raised a fresh round of funding to accelerate its aim of helping to bring drugs and treatments to market quicker and more efficiently. The $25 million Series C round was led by Northpond Ventures with participation from Founders Fund, Sands Capital Ventures, Bill Maris’ Section 32 venture fund, and Borealis Ventures. Read More

By | February 14th, 2019|News|

Adimab Provides 2018 Update on Clinical Pipeline

Adimab, LLC, the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, today announced that 12 new partner programs entered clinical development in 2018. This brings the total number of Adimab partner programs that have entered the clinic to 21. Read More

By | January 9th, 2019|Dartmouth Innovation, New Hampshire, News|

FierceBiotech Names Compass Therapeutics a 2018 “Fierce 15” Biotech Company

Compass Therapeutics, a biotechnology company committed to the ambitious goal of comprehensively drugging the human immune system, today announced that it has been named by FierceBiotech as one of 2018’s Fierce 15 biotechnology companies, designating it as one of the most promising private biotech companies in the industry. Compass, which completed its $132 million Series [...]

By | October 2nd, 2018|Dartmouth Innovation, News|

Vets First Choice Wins Approval to Build New Headquarters in Downtown Portland

Vets First Choice has received city approval to commence construction of a new headquarters in Portland, Maine to support its rapid growth and expansion. The new approximately 170,000 square foot facility will support more than 1,500 employees, including a state-of-the-art pharmacy facility, enhanced software and data science labs, and office space. “We’re thrilled to announce [...]

By | September 26th, 2018|Dartmouth Innovation, News|

Evox Therapeutics completes £35 million Series B financing

Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics company, today announces that it has raised £35.5 million ($45.4 million) of new capital in a Series B financing round. Redmile Group led the financing with significant new investments from GV (formerly Google Ventures) and Cowen Healthcare Investments, alongside investments from Panacea Healthcare Venture, [...]

By | September 3rd, 2018|Dartmouth Innovation, News|

Compass Therapeutics Completes $132 Million Series A Financing to Advance Next-generation Antibody-based Therapeutics into the Clinic

Compass Therapeutics, a biotechnology company committed to the ambitious goal of comprehensively drugging the human immune system, today announced the closing of the final $49 million of its $132 million Series A financing. This financing will enable the company to advance its next-generation antibody-based therapeutics into the clinic. The financing was led by OrbiMed Advisors [...]

By | July 12th, 2018|Dartmouth Innovation, New Hampshire, News|

Autodesk acquires Assemble Systems to build up its construction tech vertical

Autodesk has made a name for itself among designers, engineers and architects with its 3D and other modelling software. Now, as it continues to build out its business in adjacent business areas like construction, it has acquired Assemble Systems, a startup that has built a platform to help plan and run building projects — and [...]

By | July 9th, 2018|Design & Engineering Software, News|

Peptide Display Company Orbit Discovery Closes £6.9M Series A Financing

Orbit Discovery Ltd, an Oxford, UK-based biotech company developing an industry-leading peptide identification and optimisation platform, today announced the closing of a £6.9M Series A Financing. The round was led by Oxford Sciences Innovation who were joined by new investors RT Ventures, Borealis Ventures, Perivoli Innovations, along with further investment from all existing investors and [...]

By | May 23rd, 2018|Dartmouth Innovation, News|

Vets First Choice To Merge With Henry Schein Animal Health

Henry Schein, Inc. (Nasdaq: HSIC) and Vets First Choice announced plans today for Henry Schein to spin off its Animal Health business and merge it with Vets First Choice, creating an innovative approach to advancing the delivery of animal health care designed to provide unique benefits to veterinarians, manufacturers, pet owners, and their pets. The [...]

By | April 23rd, 2018|News|